Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Platelet Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01585259
What this trial is testing

Anfibatide Phase Ib-IIa Clinical Trial

Who this might be right for
Non-ST Segment Elevation Myocardial Infarction
Lee's Pharmaceutical Limited 90
Post-approval studies (Phase 4)UnknownNCT03908593
What this trial is testing

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Who this might be right for
Gastrointestinal Ulcer (Peptic) or ErosionAnti-Platelet TherapyCoronary Artery Bypass
Ruijin Hospital 232
Post-approval studies (Phase 4)Study completedNCT03252249
What this trial is testing

Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

Who this might be right for
Acute Coronary SyndromeCoronary Artery Disease
University of Edinburgh 5,094
Testing effectiveness (Phase 2)UnknownNCT05983952
What this trial is testing

Anti-CD38 Antibody Treating APS With Thrombocytopenia

Who this might be right for
Antiphospholipid SyndromeThrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 10
Post-approval studies (Phase 4)UnknownNCT03182855
What this trial is testing

Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionSTEMI - ST Elevation Myocardial Infarction
University of Aarhus 80
Not applicableStudy completedNCT05581238
What this trial is testing

Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.

Who this might be right for
Platelet AggregationBlood Transfusion
Medisch Spectrum Twente 6,428
Early research (Phase 1)Not Yet RecruitingNCT07574073
What this trial is testing

CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Who this might be right for
Anti-CD20 Monoclonal AntibodyBTK InhibitorsImmune Thrombocytopenia (ITP)+1 more
Qi deng 30
Testing effectiveness (Phase 2)Study completedNCT00642174
What this trial is testing

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Who this might be right for
Diabetes MellitusCoronary Artery Disease
Eli Lilly and Company 35
Not applicableNot Yet RecruitingNCT07140133
What this trial is testing

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Who this might be right for
High Bleeding Risk PatientsCardiologyStent Implantation+1 more
University Hospital, Grenoble 1,200
Not applicableStudy completedNCT02699008
What this trial is testing

High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay

Who this might be right for
Acute Coronary Syndrome
Wuhan Asia Heart Hospital 477
Testing effectiveness (Phase 2)Study completedNCT03487406
What this trial is testing

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Newcastle-upon-Tyne Hospitals NHS Trust 120
Post-approval studies (Phase 4)WithdrawnNCT02144831
What this trial is testing

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

Who this might be right for
Transient Ischemic AttacksMinor Stroke
University of Alberta
Post-approval studies (Phase 4)UnknownNCT01267734
What this trial is testing

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen

Who this might be right for
Coronary Heart Disease
Seoul National University Hospital 3,750
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Not applicableStudy completedNCT03526614
What this trial is testing

REpetitive Assessement of SCOREs in Patients on Dual Antiplatelet Therapy

Who this might be right for
Dual Anti-platelet Therapy
University of Roma La Sapienza 480
Not applicableLooking for participantsNCT05907629
What this trial is testing

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Who this might be right for
StrokeIntracranial Atherosclerotic Stenosis (ICAS)
Yale University 300
Post-approval studies (Phase 4)Study completedNCT05827484
What this trial is testing

The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

Who this might be right for
PRPLosartanMuscle Injury+1 more
Mostafa Hassanein, Msc 20
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT03746782
What this trial is testing

Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation

Who this might be right for
Acute Coronary Syndrome
CirQuest Labs, LLC 40
Not applicableStudy completedNCT00465218
What this trial is testing

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

Who this might be right for
Aortic Valve Disease
Ottawa Heart Institute Research Corporation 70
Next Page